Why the study?
Dilated cardiomyopathy has poor prognosis despite medical treatment, and immunoadsorption may improve cardiac function by removing pathogenic antibodies.
Case Report (n=1)
No
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Soltész et al. (2018) conducted a case report in Idiopathic dilated cardiomyopathy (n=1). Immunoadsorption was evaluated on Ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: